Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

Ohio State Wexner CEO resigns after ‘no confidence’ letter from physicians

Sheldon Retchin, MD, has stepped down as CEO of Ohio State Wexner Medical Center after physicians and faculty complained about his management style in letters to university leaders, alleging he disrespected the hospital’s mission and set “unrealistic” goals on clinical and research initiatives. 

IBM uses big data to detect Ebola's spread in animals

IBM researchers have announced new strategies in detecting and treating Ebola. They are using big data analytics to identify infected animal carriers, previously unstudied as a spread of the disease, to understand how the disease spreads.

CBO report on AHCA impact coming later in May

The Congressional Budget Office (CBO) will release an updated report on how the American Health Care Act (AHCA) could affect insurance coverage and federal healthcare spending, with the score expected to be released the week of May 22.

Aetna completely out of ACA exchanges for 2018

Making good on promises made by its CEO earlier this year, Aetna confirmed it will not offer policies on the Affordable Care Act (ACA) exchanges in any market for 2018. 

New Jersey hospital deal collapses after gaining state approval

Ontario, California-based Prime Healthcare Foundation won regulatory approval on May 8 to buy Salem, New Jersey-based Memorial Hospital of Salem County—but then decided to scuttle the deal the very same day.

HHS criticized over ‘potentially illegal’ memo

Republicans in Congress were critical of a memo circulated to HHS employees instructing them not to speak to federal lawmakers or their staffs without first clearing it with department leadership, saying it may infringe on the rights of whistleblowers.

Blue Cross Blue Shield steps in as lone exchange insurer in some Tennessee markets

Blue Cross Blue Shield of Tennessee plans on selling individual market plans next year in the Knoxsville area, which had been in danger of having no participating insurer on the Affordable Care Act exchanges for 2018.

Thumbnail

Scott Gottlieb confirmed as FDA commissioner

The U.S. Senate confirmed Scott Gottlieb, MD, as the new commissioner of the Food and Drug Administration (FDA), bringing the former deputy commissioner back to lead the agency. 

Displaying 4657 - 4664 of 6647

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup